Scienture Holdings, Inc. SCNX 深 滬
已收盤 02-06 16:00:00 美东时间
0.4776
+0.048
+11.07%
華盛通- 最 高0.48
- 今 開0.43
- 成交量 48.34万股
- 最 低 0.4297
- 昨 收 0.43
- 總市值 1940.53万
- 52周最高 3.61
- 市盈率 靜 --
- 換手率 1.19%
- 52周最低 0.4248
- 委 比 -98.46%
- 總股本 4063.08万
- 歷史最高 164.50
- 量 比 0.63
- 振 幅 11.70%
- 歷史最低 -5.81
- 每 手 1
- 風險率 0.70%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多SCIENTURE HOLDINGS Reaffirms Plan To Commercially Roll Out REZENOPY In Q2
SCIENTURE HOLDINGS, INC. (NASDAQ:SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through the development,
02-03 21:21
Scienture Expands Access to ARBLI and Prepares for Launch of REZENOPY in 2026
SCIENTURE HOLDINGS, INC. (NASDAQ:SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through the development,
02-03 21:20
EXCLUSIVE: Penny Stock Scienture's Partner Secures US Patent For Highest Dosage Naloxone Spray For Emergency Opioid Overdose Treatment
New US patent strengthens protection for Rezenopy, the FDA-approved 10 mg naloxone nasal spray.
01-14 20:51
Scienture Advances Commercial Launch Of FDA-Approved REZENOPY Following Exclusive U.S. Commercialization Agreement
U.S. Naloxone Market: ~$154 million in annual sales and 9.3 million units annuallyCOMMACK, NY, Dec. 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ:SCNX), a holding company for existing and planned
2025-12-22 21:07
Why Is Scienture Stock Gaining Today?
Scienture stock is climbing after the company partnered with BlinkRx to expand national access to its new FDA-approved liquid losartan therapy, Arbli.
2025-12-10 22:53
Scienture Holdings Q3 EPS $(0.19) Up From $(1.34) YoY, Sales $590.050K Up From $64.861K YoY
Scienture Holdings (NASDAQ:SCNX) reported quarterly losses of $(0.19) per share. This is a 85.82 percent increase over losses of $(1.34) per share from the same period last year. The company reported $590.050 thousand
2025-11-13 21:21
EXCLUSIVE: Scienture Delivers Q3 Revenue Jump With Arbli Sales And Debt Reduction
Scienture's Q3 revenue surged on Arbli sales, debt dropped, and cash rose to $8 million ahead of its planned Rezenopy launch in early 2026.
2025-11-13 20:50
Scienture Holdings, Inc. shares are trading higher after the company announced that Arbli (losartan potassium) oral suspension was added to key national payor formularies, expanding commercial and Medicare coverage.
Scienture Holdings, Inc. shares are trading higher after the company announced ...
2025-11-04 20:55
Why Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Shares of Intel Corporation (NASDAQ:INTC) rose sharply in pre-market trading af...
2025-10-24 17:25
Scienture Holdings Stock Is Soaring Thursday: What's Fueling The Momentum?
Shares of Scienture Holdings, Inc. (NASDAQ: SCNX) are rising Thursday after the company announced the start of commercial sales for Arbli.
2025-10-24 01:14
